Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report)’s share price rose 1.4% during mid-day trading on Thursday . The stock traded as high as $0.6995 and last traded at $0.6995. Approximately 564 shares changed hands during mid-day trading, a decline of 79% from the average daily volume of 2,738 shares. The stock had previously closed at $0.6899.
Vaccinex Price Performance
The business has a fifty day moving average price of $0.62 and a 200 day moving average price of $0.69. The company has a market capitalization of $1.82 million, a P/E ratio of -0.01 and a beta of 1.10.
Vaccinex Company Profile
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Recommended Stories
- Five stocks we like better than Vaccinex
- How to Plot Fibonacci Price Inflection Levels
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- Canada Bond Market Holiday: How to Invest and Trade
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- The Risks of Owning Bonds
- MarketBeat Week in Review – 12/1 – 12/5
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
